PHILADELPHIA — This is not the Tony DeAngelo Revenge Tour. It is not about proving something to the teams that cast him off or those that did not sign him over the summer. It is about the here ...

EAST MEADOW, NY -- There's no question that the New York Islanders signing of Tony DeAngelo was controversial. Everyone is entitled to their own opinion, and a portion of the fan base was up in ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work with the University of Oxford on a cancer vaccine research program.

That was a significant reason the Islanders signed Tony DeAngelo, a known power-play specialist, on Friday before trading for Scott Perunovich on Monday. In DeAngelo's season debut, a 3-2 ...

And with his latest signing of Tony DeAngelo, that tells us one thing: The Islanders' playoff push is still on. DeAngelo's past has vilified him in the hockey community, especially among the NHL ...

Tony DeAngelo is back in the NHL, signing with the New York Islanders for the rest of the 2024-25 season. The contract, announced Friday, is for the league minimum salary of $775,000 and is ...

With Noah Dobson out week-to-week, the New York Islanders brought in 29-year-old Tony DeAngelo on Friday. The hope is that the puck-moving power-play specialist can help Long Island remain in ...

There will be one change to the backend as Tony DeAngelo, who was signed to a one-year prorated contract, will make his season debut. He'll slot in alongside Alexander Romanov and play on the top ...

Pharmaceutical giant GSK and the University of Oxford have teamed up to make a vaccine that targets cells at the pre-cancerous stage. The university has world-leading expertise in the study of pre ...

Romanov offers more broad coverage in multiple categories. If you're looking for points, especially on the power play, DeAngelo has looked pretty good so far. He'll face his former coach in John ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...